Treatment-resistant ER+ breast cancers with the worst prognosis may have PKMYT1 as their "Achilles heel.".

Published Date: 29 May 2024

Patients with tumors expressing estrogen receptor-alpha account for up to 80% of breast cancer-related deaths. Even so, standard treatment for these estrogen receptor-positive (ER+) breast cancers usually results in some response at first.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

2.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

3.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

CDC Alerts on Dramatic Rise in Human Parvovirus B19


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot